Pfizer antibiotic shows upped risk when taken

Late last week, the FDA issued a safety alert over Pfizer's Zyvox antibiotic product which found a higher chance of death in seriously ill patients after being given the drugs. Although the results came from clinical trials of the medicine, this is yet another disturbing situation about prescription drugs that have very unfortunate side effects.

The clinical trial involved Zyvox being compared to three rival drugs: vancomycin, oxacillin and dicloxacillin. The trial's results concluded that Zyvox patients infected certain types of bacteria saw a greater risk of death -- and the only excluded group was those infected with gram-positive bacteria.